The effects of hypertension on the paediatric brain: A justifiable concern

The Lancet Neurology

Volumn 9, Issue 9, 2010, Pages 933-940

  Sharma, Madhu ^a   Kupferman, Juan C ^a,b   Brosgol, Yuri ^a   Paterno, Kara ^a   Goodman, Sharon ^a   Prohovnik, Isak ^c   Kirkham, Fenella J ^d   Pavlakis, Steven G ^a,c  

^a MAIMONIDES MEDICAL CENTER   (United States)

^b STATE UNIVERSITY OF NEW YORK   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CORTICOSTEROID; STEROID;

ADVERSE OUTCOME; ATHEROSCLEROSIS; BLOOD PRESSURE MONITORING; BRAIN; BRAIN BLOOD FLOW; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CENTRAL NERVOUS SYSTEM; CLINICAL STUDY; COGNITIVE DEFECT; DISEASE COURSE; HUMAN; HYPERTENSION; JUVENILE RHEUMATOID ARTHRITIS; LEARNING DISORDER; MOTOR PERFORMANCE; NOTE; PEDIATRICS; POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME; PRIORITY JOURNAL; STROKE; VASCULAR DISEASE;

EID: 77955662357     PISSN: 14744422     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1474-4422(10)70167-8     Document Type: Note

References (79)

1. Rosner B, Cook N, Portman R, Daniels S, Falkner B Blood pressure differences by ethnic group among United States children and adolescents. Hypertension 2009, 54:502-508.
2. Flynn JT Pediatric hypertension: recent trends and accomplishments, future challenges. Am J Hypertens 2008, 21:605-612.
3. Sorof JM, Lai D, Turner J, Poffenbarger T, Portman RJ Overweight, ethnicity, and the prevalence of hypertension in school-aged children. Pediatrics 2004, 113:475-482.
4. Ogden CL, Carroll MD, Curtin LR, Lamb MM, Flegal KM Prevalence of high body mass index in US children and adolescents, 2007-2008. JAMA 2010, 303:242-249.
5. Treatment options for type 2 diabetes in adolescents and youth: a study of the comparative efficacy of metformin alone or in combination with rosiglitazone or lifestyle intervention in adolescents with type 2 diabetes. Pediatr Diabetes 2007, 8:74-87. The TODAY Study Group.
6. Pinhas-Hamiel O, Zeitler P Acute and chronic complications of type 2 diabetes mellitus in children and adolescents. Lancet 2007, 369:1823-1831.
7. Sorof J, Daniels S Obesity hypertension in children: a problem of epidemic proportions. Hypertension 2002, 40:441-450.
8. Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003, 42:1206-1252. the National High Blood Pressure Education Program Coordinating Committee.
9. Rothwell PM Limitations of the usual blood-pressure hypothesis and importance of variability, instability, and episodic hypertension. Lancet 2010, 375:938-948.
10. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 2004, 114:555-576. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents.
11. Urbina E, Alpert B, Flynn J, et al. Ambulatory blood pressure monitoring in children and adolescents: recommendations for standard assessment-a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee of the Council on Cardiovascular Disease in the Young and the Council for High Blood Pressure Research. Hypertension 2008, 52:433-451.
12. Collins RT, Alpert BS Pre-hypertension and hypertension in pediatrics: don't let the statistics hide the pathology. J Pediatr 2009, 155:165-169.
13. Hansen ML, Gunn PW, Kaelber DC Underdiagnosis of hypertension in children and adolescents. JAMA 2007, 298:874-879.
14. Jones BV, Egelhoff JC, Patterson RJ Hypertensive encephalopathy in children. AJNR Am J Neuroradiol 1997, 18:101-106.
15. Menkes JH, Fink BW, Hurvitz CGH, Hyman CB, Jordan SC, Watanabe F Neurologic manifestations of systemic disease. Child neurology 2000, 1120-1121. Lippincott Williams & Wilkins, Philadelphia. 6th edn. J.H. Menkes, H.B. Sarnat (Eds.).
16. Chillon JM, Baumbach GL Autoregulation of cerebral blood flow. Primer on cerebrovascular diseases 1997, 51-54. Academic Press, San Diego. 2nd edn. K.M.A. Welch, L.R. Caplan, D.J. Reis, B.K. Siesjö, B. Weir (Eds.).
17. Strandgaard S, Olesen J, Skinhoj E, Lassen NA Autoregulation of brain circulation in severe arterial hypertension. Br Med J 1973, 1:507-510.
18. Paulson OB, Strandgaard S, Edvinsson L Cerebral autoregulation. Cerebrovasc Brain Metab Rev 1990, 2:161-192.
19. Strandgaard S, Paulson OB Cerebral autoregulation. Stroke 1984, 15:413-416.
20. Manolio TA, Olson J, Longstreth WT Hypertension and cognitive function: pathophysiologic effects of hypertension on the brain. Curr Hypertens Rep 2003, 5:255-261.
21. Hachinski V The 2005 Thomas Willis Lecture: stroke and vascular cognitive impairment: a transdisciplinary, translational and transactional approach. Stroke 2007, 38:1396.
22. Chalmers J, Todd A, Chapman N, et al. International Society of Hypertension (ISH): statement on blood pressure lowering and stroke prevention. J Hypertens 2003, 21:651-663. for the International Society of Hypertension Writing Group.
23. Seshadri S, Beiser A, Kelly-Hayes M, et al. The lifetime risk of stroke: estimates from the Framingham Study. Stroke 2006, 37:345-350.
24. Simon RP, Greenberg DA, Aminoff MJ Stroke. Clinical neurology 2009, 292-327. McGraw-Hill, New York. 7th edn. R.P. Simon, D.A. Greenberg, M.J. Aminoff (Eds.).
25. Kilander L, Nyman H, Boberg M, Hansson L, Lithell H Hypertension is related to cognitive impairment: a 20-year follow-up of 999 men. Hypertension 1998, 31:780-786.
26. Kuo H-K, Sorond F, Iloputaife I, Gagnon M, Milberg W, Lipsitz LA Effect of blood pressure on cognitive functions in elderly persons. J Gerontol A Biol Sci Med Sci 2004, 59:1191-1194.
27. Semplicini A, Inverso G Antihypertensive treatment and cognitive function: another tempest in a P pot?. J Hypertens 2008, 26:1551-1552.
28. Patel HP, Mitsnefes M Advances in the pathogenesis and management of hypertensive crisis. Curr Opin Pediatr 2005, 17:210-214.
29. Flynn JT, Tullus K Severe hypertension in children and adolescents: pathophysiology and treatment. Pediatr Nephrol 2009, 24:1101-1112.
30. Deal JE, Barratt TM, Dillon MJ Management of hypertensive emergencies. Arch Dis Child 1992, 67:1089-1092.
31. Hulse JA, Taylor DSI, Dillon MJ Blindness and paraplegia in severe childhood hypertension. Lancet 1979, 314:553-556.
32. Thomas WJ, Sahney S, Siegel LM Acute visual loss in a child with autosomal recessive polycystic kidney disease: case report and review of the literature. J AAPOS 2003, 7:217-220.
33. Sébire G, Husson B, Lasser C, Tardieu M, Dommergues JP, Landrieu P Encephalopathy induced by arterial hypertension: clinical, radiological and therapeutical aspects. Arch Pediatr 1995, 2:513-518. [in French].
34. Dienst J Children don't have strokes? Just ask Jared. New York Times (accessed July 14, 2010). http://www.nytimes.com/2010/01/19/health/19stroke.html.
35. Kirkham F, Sébire G, Steinlin M, Sträter R Arterial ischaemic stroke in children: review of the literature and strategies for future stroke studies. Thromb Haemost 2004, 92:697-706.
36. Brower MC, Rollins N, Roach ES Basal ganglia and thalamic infarction in children: cause and clinical features. Arch Neurol 1996, 53:1252-1256.
37. Choi Y, Kang BC, Kim KJ, et al. Renovascular hypertension in children with moyamoya disease. J Pediatr 1997, 131:258-263.
38. de Vries RR, Nikkels PG, van der Laag J, Broere G, Braun KP Moyamoya and extracranial vascular involvement: fibromuscular dysplasia? A report of two children. Neuropediatrics 2003, 34:318-321.
39. Ganesan V, Prengler M, McShane MA, Wade AM, Kirkham FJ Investigation of risk factors in children with arterial ischemic stroke. Ann Neurol 2003, 53:167-173.
40. Ganesan V, Chong WK, Cox TC, Chawda SJ, Prengler M, Kirkham FJ Posterior circulation stroke in childhood: risk factors and recurrence. Neurology 2002, 59:1552-1556.
41. Ganesan V, Prengler M, Wade A, Kirkham FJ Clinical and radiological recurrence after childhood arterial ischemic stroke. Circulation 2006, 114:2170-2177.
42. Kupferman JC, Singh A, Pavlakis SG Lacunar stroke and masked hypertension in an adolescent male. Pediatr Neurol 2007, 36:125-127.
43. Lurbe E Masked hypertension in children and adolescents. Curr Hypertens Rep 2008, 10:165-166.
44. Ohkubo T, Kikuya M, Metoki H, et al. Prognosis of "masked" hypertension and "white-coat" hypertension detected by 24-h ambulatory blood pressure monitoring: 10-year follow up from the Ohasama Study. J Am Coll Cardiol 2005, 46:508-515.
45. Wang JJ, Shi KL, Li JW, et al. Risk factors for arterial ischemic and hemorrhagic stroke in childhood. Pediatr Neurol 2009, 40:277-281.
46. Rakototiana AF, Ramorasata AC, Rakoto-Ratsimba HN, Hunald FA, Rajaobelison T, Rantomalala HY Pheochromocytoma revealed by stroke in a child. Arch Pediatr 2008, 15:1531-1534. [in French].
47. Nguyen JH, Lodish MB, Patronas NJ, et al. Extensive and largely reversible ischemic cerebral infarctions in a prepubertal child with hypertension and Cushing disease. J Clin Endocrinol Metab 2009, 94:1-2.
48. Pegelow CH, Colangelo L, Steinberg M, et al. Natural history of blood pressure in sickle cell disease: risks for stroke and death associated with relative hypertension in sickle cell anemia. Am J Med 1997, 102:171-177.
49. Ohene-Frempong K, Weiner SJ, Sleeper LA, et al. Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood 1998, 91:288-294. the Cooperative Study of Sickle Cell Disease.
50. Sarnaik SA, Casella JF, Barton BA, et al. Elevated systolic blood pressure and low fetal hemoglobin are risk factors for silent cerebral infarcts in children with sickle cell anemia. Blood (ASH Annual Meeting Abstracts) 2009, 114:262. (abstr).
51. Scothorn DJ, Price C, Schwartz D, et al. Risk of recurrent stroke in children with sickle cell disease receiving blood transfusion therapy for at least five years after initial stroke. J Pediatr 2002, 140:348-354.
52. Awada A, Daif A, Obeid T, Al Rajeh S Nontraumatic cerebral hemorrhage in the young: a study of 107 cases. J Stroke Cerebrovasc Dis 1998, 7:200-204.
53. Strouse JJ, Hulbert ML, DeBaun MR, Jordan LC, Casella JF Primary hemorrhagic stroke in children with sickle cell disease is associated with recent transfusion and use of corticosteroids. Pediatrics 2006, 118:1916-1924.
54. Royal JE, Seeler RA Hypertension, convulsions, and cerebral hæmorrhage in sickle-cell anaemia patients after blood-transfusions. Lancet 1978, 312:1207.
55. Whitworth JA, Brown MA, Kelly JJ, Williamson PM Mechanisms of cortisol-induced hypertension in humans. Steroids 1995, 60:76-80.
56. Moorthy S, Subramaniam TS, Prabhu NK, Sree KKP, Nair RG Posterior reversible encephalopathy syndrome in a child with pheochromocytoma. Indian J Radiol Imaging 2002, 12:321-324.
57. Wirrell EC, Hamiwka LD, Hamiwka LA, Grisaru S, Wei X Acute glomerulonephritis presenting with PRES: a report of 4 cases. Can J Neurol Sci 2007, 34:316-321.
58. Rubin AM, Kang H Cerebral blindness and encephalopathy with cyclosporin A toxicity. Neurology 1987, 37:1072-1076.
59. Pavlakis SG, Frank Y, Chusid R Hypertensive encephalopathy, reversible occipitoparietal encephalopathy, or reversible posterior leukoencephalopathy: three names for an old syndrome. J Child Neurol 1999, 14:277-281.
60. Hinchey J, Chaves C, Appignani B, et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med 1996, 334:494-500.
61. Lee VH, Wijdicks EFM, Manno EM, Rabinstein AA Clinical spectrum of reversible posterior leukoencephalopathy syndrome. Arch Neurol 2008, 65:205-210.
62. Schwartz RB, Jones KM, Kalina P, et al. Hypertensive encephalopathy: findings on CT, MR imaging, and SPECT imaging in 14 cases. AJR Am J Roentgenol 1992, 159:379-383.
63. Beausang-Linder M, Bill A Cerebral circulation in acute arterial hypertension: protective effects of sympathetic nervous activity. Acta Physiol Scand 1981, 111:193-199.
64. Stott VL, Hurrell MA, Anderson TJ Reversible posterior leukoencephalopathy syndrome: a misnomer reviewed. Intern Med J 2005, 35:83-90.
65. Lande MB, Kaczorowski JM, Auinger P, Schwartz GJ, Weitzman M Elevated blood pressure and decreased cognitive function among school-age children and adolescents in the United Status. J Pediatr 2003, 143:720-724.
66. Suhr JA, Stewart JC, France CR The relationship between blood pressure and cognitive performance in the Third National Health and Nutrition Examination Survey (NHANES III). Psychosom Med 2004, 66:291-297.
67. Lande MB, Schwartz GJ, Falkner B Treatment of pediatric primary hypertension is associated with improvement in neurocognitive function. J Clin Hypertens 2008, 10(5 suppl A):A3.
68. Lande MB, Adams H, Ogawa M Cognitive function in a 1-year, open-label study of the safety of eplerenone in children. J Clin Hypertens 2008, 10(5 suppl A):A154.
69. Lande MB, Adams H, Falkner F, et al. Parental assessment of executive function and internalizing and externalizing behavior in primary hypertension after anti-hypertensive therapy. J Pediatr 2010, 157:114-119.
70. Effect of high blood pressure and antihypertensive treatment on brain functioning in children. (accessed July 14, 2010). http://www.clinicaltrials.gov/ct2/show/NCT00178490.
71. Master AM, Dack S, Jaffe HL Age, sex and hypertension in myocardial infarction due to coronary occlusion. Arch Intern Med 1939, 64:767-786.
72. McGill HC, Strong JP, Tracy RE, McMahan CA, Oalmann MC Relation of a postmortem renal index of hypertension to atherosclerosis in youth. Arterioscler Thromb Vasc Biol 1995, 15:2222-2228. the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group.
73. Urbina E, Williams RV, Alpert BS, et al. Noninvasive assessment of subclinical atherosclerosis in children and adolescents: recommendations for standard assessment for clinical research-a scientific statement from the American Heart Association. Hypertension 2009, 54:919-950.
74. Lande MB, Carson NL, Roy J, Meagher CC Effects of childhood primary hypertension on carotid intima media thickness: a matched controlled study. Hypertension 2006, 48:40-44.
75. Le J, Zhang D, Menees S, Chen J, Raghuveer G "Vascular age" is advanced in children with atherosclerosis-promoting risk factors. Circ Cardiovasc Imaging 2010, 3:8-14.
76. Brosgol Y, Kupferman JC, Goodman S, Paterno K, Pavlakis S Transcranial doppler reactivity (TCR) abnormalities in pediatric hypertension: a potential biomarker for brain abnormalities. Ann Neurol 2009, 66(suppl 13):S144.
77. Prohovnik I, Hurlet-Jensen A, Adams R, De Vivo D, Pavlakis SG Hemodynamic etiology of elevated flow velocity and stroke in sickle-cell disease. J Cereb Blood Flow Metab 2009, 29:803-810.
78. Urbina EM, Kieltkya L, Tsai J, Srinivasan SR, Berenson GS Impact of multiple cardiovascular risk factors on brachial artery distensibility in young adults: the Bogalusa Heart Study. Am J Hypertens 2005, 18:767-771.
79. Croix B, Feig DI Childhood hypertension is not a silent disease. Pediatr Nephrol 2006, 21:527-532.